{{Rsnum
|rsid=7260598
|Gene=LOC100996381
|Chromosome=19
|position=24039984
|Orientation=plus
|GMAF=0.1483
|Gene_s=LOC100996381
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 74.3 | 24.8 | 0.9
| HCB | 68.6 | 30.7 | 0.7
| JPT | 77.0 | 23.0 | 0.0
| YRI | 67.3 | 30.6 | 2.0
| ASW | 70.2 | 26.3 | 3.5
| CHB | 68.6 | 30.7 | 0.7
| CHD | 65.1 | 33.0 | 1.8
| GIH | 75.2 | 20.8 | 4.0
| LWK | 63.6 | 32.7 | 3.6
| MEX | 79.3 | 17.2 | 3.4
| MKK | 62.8 | 34.6 | 2.6
| TSI | 69.6 | 30.4 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (placlitaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=6E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}